AAAAAA

   
Results: 1-11 |
Results: 11
A phase II trial of bryostatin 1 in the treatment of metastatic colorectalcancer
Authors: Zonder, JA Shields, AF Zalupski, M Chaplen, R Heilbrun, LK Arlauskas, P Philip, PA
Citation: Ja. Zonder et al., A phase II trial of bryostatin 1 in the treatment of metastatic colorectalcancer, CLIN CANC R, 7(1), 2001, pp. 38-42
Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters
Authors: Merati, K Siadaty, MS Andea, A Sarkar, F Ben-Josef, E Mohammad, R Philip, P Shields, AF Vaitkevicius, V Grignon, DJ Adsay, NV
Citation: K. Merati et al., Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters, AM J CL ONC, 24(5), 2001, pp. 447-452
Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer
Authors: Shields, AF Lange, M Zalupski, MM
Citation: Af. Shields et al., Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer, AM J CL ONC, 24(1), 2001, pp. 96-98
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma
Authors: Philip, PA Zalupski, MM Vaitkevicius, VK Arlauskas, P Chaplen, R Heilbrun, LK Adsay, V Weaver, D Shields, AF
Citation: Pa. Philip et al., Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma, CANCER, 92(3), 2001, pp. 569-577
Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors
Authors: Mankoff, DA Dehdashti, F Shields, AF
Citation: Da. Mankoff et al., Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors, NEOPLASIA, 2(1-2), 2000, pp. 71-88
Radiosynthesis of 3 '-deoxy-3 '-[F-18]fluorothymidine: [F-18]FLT for imaging of cellular proliferation in vivo
Authors: Grierson, JR Shields, AF
Citation: Jr. Grierson et Af. Shields, Radiosynthesis of 3 '-deoxy-3 '-[F-18]fluorothymidine: [F-18]FLT for imaging of cellular proliferation in vivo, NUCL MED BI, 27(2), 2000, pp. 143-156
Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma - A phase II study
Authors: Ahmed, S Vaitkevicius, VK Zalupski, MM Du, W Arlauskas, P Gordon, C Kellogg, C Shields, AF
Citation: S. Ahmed et al., Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma - A phase II study, AM J CL ONC, 23(4), 2000, pp. 420-424
Cost analysis of pancreatic carcinoma treatment
Authors: Du, W Touchette, D Vaitkevicius, VK Peters, WP Shields, AF
Citation: W. Du et al., Cost analysis of pancreatic carcinoma treatment, CANCER, 89(9), 2000, pp. 1917-1924
Phase II study of CI-958 in colorectal cancer
Authors: Shields, AF Philip, PA LoRusso, PM Ferris, AM Zalupski, MM
Citation: Af. Shields et al., Phase II study of CI-958 in colorectal cancer, CANC CHEMOT, 43(2), 1999, pp. 162-164
Kinetic analysis of 2-[C-11]Thymidine PET imaging studies: Validation studies
Authors: Mankoff, DA Shields, AF Link, JM Graham, MM Muzi, M Peterson, LM Eary, JF Krohn, KA
Citation: Da. Mankoff et al., Kinetic analysis of 2-[C-11]Thymidine PET imaging studies: Validation studies, J NUCL MED, 40(4), 1999, pp. 614-624
The role of imaging in the development of oncologic agents
Authors: Shields, AF Ho, PTC Grierson, JR
Citation: Af. Shields et al., The role of imaging in the development of oncologic agents, J CLIN PHAR, 39, 1999, pp. 40S-44S
Risultati: 1-11 |